83
Views
32
CrossRef citations to date
0
Altmetric
CaseReport Article

Cure of Pulmonary Rhizomucor Pusillus Infection in a Patient with Hairy-Cell Leukemia: Role of Liposomal Amphotericin B and GM-CSF

, , &
Pages 1393-1399 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Masatomo Kimura, Shun-Ichi Udagawa, Koichi Makimura, Kazuo Satoh, Noritsuna Toyazaki & Hiroyuki Ito. (2009) Isolation and identification of Rhizomucor pusillus from pleural zygomycosis in an immunocompetent patient. Medical Mycology 47:8, pages 869-873.
Read now
B Gleissner, A Schilling, I Anagnostopolous, I Siehl & E Thiel. (2004) Improved Outcome of Zygomycosis in Patients with Hematological Diseases?. Leukemia & Lymphoma 45:7, pages 1351-1360.
Read now

Articles from other publishers (30)

Disha Kesharwani, Sandhya Mishra, Bhumika Verma, Kamini Verma & Suraj Banjare. (2023) DIAGNOSIS AND TREATMENT OF MUCORMYCOSIS: AN INTRUDER POST-COVID-19. Asian Journal of Pharmaceutical and Clinical Research, pages 24-29.
Crossref
Nuobing Yang, Lining Zhang & Sizhou Feng. (2023) Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies. Journal of Fungi 9:5, pages 592.
Crossref
Tempe K Chen, Jagmohan S Batra, David E Michalik, Jacqueline Casillas, Ramesh Patel, Maritza E Ruiz, Harneet Hara, Bhavita Patel, Meena Kadapakkam, James Ch'Ng, Catherine B Small, Panagiotis Zagaliotis, Carolyn E Ragsdale, Luis O Leal, Emmanuel Roilides & Thomas J Walsh. (2022) Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases. Open Forum Infectious Diseases 9:11.
Crossref
Mona G Alshahawey, Ghadir S El-Housseiny, Noha S Elsayed, Mohammad Y Alshahrani, Lamia M EL Wakeel & Khaled M Aboshanab. (2022) New insights on mucormycosis and its association with the COVID-19 pandemic. Future Science OA 8:2.
Crossref
Hillard M. Lazarus, Carolyn E. Ragsdale, Robert Peter Gale & Gary H. Lyman. (2021) Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?. Frontiers in Immunology 12.
Crossref
Julie M. Steinbrink & Marisa H. Miceli. (2021) Mucormycosis. Infectious Disease Clinics of North America 35:2, pages 435-452.
Crossref
Lingyue Sun, Shuzhen Zhang, Zhe Wan, Ruoyu Li & Jin Yu. (2021) In Vivo and In Vitro Impairments in T Helper Cell and Neutrophil Responses against Mucor irregularis in Card9 Knockout Mice . Infection and Immunity 89:5.
Crossref
K. Brunet & B. Rammaert. (2020) Mucormycosis treatment: Recommendations, latest advances, and perspectives. Journal de Mycologie Médicale 30:3, pages 101007.
Crossref
Dulce Iliana Navarro Vergara, Gloria Barragán Pola, Alexandro Bonifaz, Carlos Núñez Pérez-Redondo, Omar Choreño García & Raúl Cicero Sabido. (2017) Mucormicosis pulmonar en un paciente con trasplante renal y hemoptisis incoercible. Revista Iberoamericana de Micología 34:4, pages 233-236.
Crossref
Marisa H. Miceli & Carol A. Kauffman. (2015) Treatment Options for Mucormycosis. Current Treatment Options in Infectious Diseases 7:3, pages 142-154.
Crossref
Emmanuel Roilides, Charalampos Antachopoulos & Maria Simitsopoulou. (2014) Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs. Mycoses 57:s3, pages 40-47.
Crossref
Maria J. G. T. Vehreschild, Kerstin Wahlers & Oliver A. Cornely. 2014. Human Fungal Pathogens. Human Fungal Pathogens 263 280 .
Vicki A. Morrison. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients 319 349 .
A. Katragkou & E. Roilides. (2012) Immunotherapy of infections caused by rare filamentous fungi. Clinical Microbiology and Infection 18:2, pages 134-139.
Crossref
Charalampos Antachopoulos, Aspasia Katragkou & Emmanuel Roilides. (2012) Immunotherapy against invasive mold infections. Immunotherapy 4:1, pages 107-120.
Crossref
Marisa Z. R. Gomes, Russell E. Lewis & Dimitrios P. Kontoyiannis. (2011) Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species. Clinical Microbiology Reviews 24:2, pages 411-445.
Crossref
Ashraf S. Ibrahim, John E. EdwardsJrJr, Scott G. Filler & Brad Spellberg. 2011. Essentials of Clinical Mycology. Essentials of Clinical Mycology 265 280 .
David H. Ellis. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
Mohammad Shahid, Trivendra Tripathi, Nancy Khardori, Anwar Huq & Iqbal Ahmad. 2010. Combating Fungal Infections. Combating Fungal Infections 373 396 .
Walter Dehority, Jennifer Willert & Alice Pong. (2009) Zygomycetes Infections in Pediatric HematologyOncology Patients. Journal of Pediatric Hematology/Oncology 31:12, pages 911-919.
Crossref
George L. Petrikkos & Anna Skiada. (2009) New developments in the treatment of zygomycosis. Current Fungal Infection Reports 3:4, pages 223-228.
Crossref
Shellee A. Grim & Nina M. Clark. (2009) The role of adjuvant agents in treating fungal diseases. Current Fungal Infection Reports 3:2, pages 117-126.
Crossref
I. O. Kara, Y. Tasova, A. Uguz & B. Sahin. (2009) Mucormycosis-associated fungal infections in patients with haematologic malignancies. International Journal of Clinical Practice 63:1, pages 134-139.
Crossref
Mark A. Hoffman. (2006) Clinical Presentations and Complications of Hairy Cell Leukemia. Hematology/Oncology Clinics of North America 20:5, pages 1065-1073.
Crossref
Stefan Monecke, Kristina Hochauf, Birgit Gottschlich & Ralf Ehricht. (2006) A case of peritonitis caused by Rhizopus microsporus. Mycoses 49:2, pages 139-142.
Crossref
Peter C. Iwen, Alison G. Freifeld, Lynne Sigler & Stefano R. Tarantolo. (2005) Molecular Identification of Rhizomucor pusillus as a Cause of Sinus-Orbital Zygomycosis in a Patient with Acute Myelogenous Leukemia . Journal of Clinical Microbiology 43:11, pages 5819-5821.
Crossref
M. M. Roden, T. E. Zaoutis, W. L. Buchanan, T. A. Knudsen, T. A. Sarkisova, R. L. Schaufele, M. Sein, T. Sein, C. C. Chiou, J. H. Chu, D. P. Kontoyiannis & T. J. Walsh. (2005) Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases. Clinical Infectious Diseases 41:5, pages 634-653.
Crossref
Charalampos Antachopoulos & Emmanuel Roilides. (2005) Cytokines and fungal infections. British Journal of Haematology 129:5, pages 583-596.
Crossref
R.M. Prabhu & R. Patel. (2004) Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clinical Microbiology and Infection 10, pages 31-47.
Crossref
Antonella Lupetti, Peter H. Nibbering, Mario Campa, Mario Del Tacca & Romano Danesi. (2003) Molecular targeted treatments for fungal infections: the role of drug combinations. Trends in Molecular Medicine 9:6, pages 269-276.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.